Literature DB >> 9563478

Polyamines regulate expression of the neoplastic phenotype in mouse skin.

A Peralta Soler1, G Gilliard, L Megosh, K George, T G O'Brien.   

Abstract

Elevated polyamine levels are characteristic of many types of neoplastic cells and tissues. We demonstrate that in transgenic mice overexpressing ornithine decarboxylase in skin, changes in tissue polyamine levels, particularly putrescine, control the development and maintenance of the neoplastic phenotype. A specific inhibitor of the transgene, alpha-difluoromethylornithine (DFMO), reversibly blocked the appearance of squamous papillomas after carcinogen treatment. Furthermore, treatment of papilloma-bearing mice with DFMO caused rapid tumor regression, also in a reversible manner. Although the rate of apoptosis in papillomas was unaffected by acute DFMO treatment, tumor cell proliferation was rapidly decreased after drug treatment. Conversely, proliferation of normal epidermal keratinocytes was unaffected by DFMO treatment. The regulatory polyamine in this model appears to be putrescine, the immediate product of ornithine decarboxylase. These results demonstrate that elevated polyamine levels are required for both the development and maintenance of the neoplastic phenotype in skin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563478

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites.

Authors:  Candace S Hayes; Karen DeFeo-Mattox; Patrick M Woster; Susan K Gilmour
Journal:  Amino Acids       Date:  2013-07-25       Impact factor: 3.520

2.  A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development.

Authors:  Candace S Hayes; Karen Defeo; Hong Dang; Carol S Trempus; Rebecca J Morris; Susan K Gilmour
Journal:  Carcinogenesis       Date:  2011-07-05       Impact factor: 4.944

3.  Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model.

Authors:  Shannon L Nowotarski; Lisa M Shantz
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

4.  Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo.

Authors:  Rachelle R Olsen; Ivy Chung; Bruce R Zetter
Journal:  Amino Acids       Date:  2011-09-11       Impact factor: 3.520

Review 5.  Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.

Authors:  Rachelle R Olsen; Bruce R Zetter
Journal:  Mol Cancer Res       Date:  2011-08-17       Impact factor: 5.852

6.  The ornithine decarboxylase gene is essential for cell survival during early murine development.

Authors:  H Pendeville; N Carpino; J C Marine; Y Takahashi; M Muller; J A Martial; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  Transcriptional and translational control of ornithine decarboxylase during Ras transformation.

Authors:  Lisa M Shantz
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

8.  Keratin-6 driven ODC expression to hair follicle keratinocytes enhances stemness and tumorigenesis by negatively regulating Notch.

Authors:  Aadithya Arumugam; Zhiping Weng; Sandeep C Chaudhary; Farrukh Afaq; Craig A Elmets; Mohammad Athar
Journal:  Biochem Biophys Res Commun       Date:  2014-08-02       Impact factor: 3.575

9.  Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions.

Authors:  Xin-Pu Miao; Jian-Sheng Li; Hui-Yan Li; Shi-Ping Zeng; Ye Zhao; Jiang-Zheng Zeng
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

10.  Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Authors:  Janet A Foote; James R Ranger-Moore; Janine G Einspahr; Kathylynn Saboda; Jaime Kenyon; James Warneke; Richard C Miller; Rayna Goldman; Min-Jian Xu; Denise J Roe; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.